• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Ketamine Treatment May Be Safe For Children With Depression

June 6, 2023 by Deborah Bloomfield

Ketamine is emerging as a promising treatment for depression in adults, with some studies indicating that the drug alleviates mental suffering in as little as 24 hours. Understandably, however, there are concerns over the pediatric use of the drug, although a new review study suggests that repeated doses of ketamine may in fact be safe for kids.

Despite its connotations as an illicit party drug, ketamine has been administered to children in medical settings for many decades. According to the study authors, “ketamine has an outstanding safety profile in children when used as a single-dose treatment, hence its extensive global use for analgesia, anesthesia and sedation.”

Advertisement

However, while the drug has shown huge potential as a treatment for depression, its therapeutic effects are transient, which means repeated doses are necessary. “Thus, there are concerns about the safety of long-term administration of ketamine apropos of the development of tolerance and whether medicinal ketamine use could serve as a gateway into illicit drug use,” write the researchers. “As such, the expansion of studies into pediatric populations has been limited.”

To investigate the safety of giving repeated doses to children, the study authors conducted a systematic review of the existing research on this topic. In total, they identified 87 cases of kids being administered ketamine over extended periods, with the highest number of doses received by a single child being 42.

Overall, they identified no serious adverse reactions. There was also no evidence of children requiring higher doses over time, indicating that none of the kids developed tolerance to the drug.

“The longest follow-up period was 6 months,” reveal the researchers. “There were no long-term consequences (including neurocognitive) reported within this time frame.”

Advertisement

Surprisingly, the study authors found that some children were even able to tolerate doses that were significantly higher than those usually administered to adults. Odd as this may seem, there is evidence to suggest that kids metabolize the drug faster than grown-ups, so such a finding is perhaps less unexpected than one would think.

Ketamine is also associated with a series of alarming side-effects that are collectively known as emergence phenomena. Resembling schizophrenia, these phenomena include delirium and hallucinations, and have been reported to occur in up to 55 percent of adult users.

However, the study authors reveal that “emergence phenomena were not reported in any of the patients in this study, which is consistent with previous reports that this frightening symptom is less common in children than adults.”

Despite the apparent safety of repeated ketamine use, though, some children did experience side-effects. The most common of these was dissociation, which accounted for 48 percent of all adverse reactions. Other negative effects included headaches and nausea, though all such reactions were mild and resolved themselves without the need for medical intervention.

Advertisement

Overall, the researchers say that their findings support the development of large-scale clinical trials into the use of repeated ketamine doses as a treatment for children with depression.

The study is published in the Journal of Psychopharmacology.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Global reinsurance rates to keep rising next year – Moody’s
  2. Italy reports 26 coronavirus deaths on Sunday, 3,838 new cases
  3. Police Claim Woman Attacked Them With Angry Bees During An Eviction
  4. Why Do Airplane Window Shades Have To Be Up During Takeoff And Landing?

Source Link: Ketamine Treatment May Be Safe For Children With Depression

Filed Under: News

Primary Sidebar

  • The “Eyes Of Clavius” Will Be Visible On The Moon Today, Thanks To Clair-Obscur Effect
  • Shockingly High Microplastic Levels Found On Remote Mediterranean Coral Reef Island
  • Interstellar Object, Cheesy Nightmares, And Smooching Orcas
  • World’s Largest Martian Meteorite Up For Auction Could Reach Whopping $2-4 Million
  • Kimalu The Beluga Whale Undergoes Pioneering Surgery And Becomes First Beluga To Survive General Aesthetic
  • The 1986 Soviet Space Mission That’s Never Been Repeated: Mir To Salyut And Back Again
  • Grisly Incident In Yellowstone National Park Shows Just How Dangerous This Vibrant Wilderness Can Be
  • Out Of All Greenhouse Gas Emitters On Earth, One US Organization Takes The Biscuit
  • Overly Ambitious Adder Attempts To Eat Hare 10 Times Its Mass In Gnarly Video
  • How Fast Does A Spacecraft Need To Go To Escape The Solar System?
  • President Trump’s Cuts To USAID Could Result In A “Staggering” 14 Million Avoidable Deaths By 2030
  • Dzo: Hybrids Beasts That Are Perfectly Crafted For Life On Earth’s Highest Mountains
  • “Rarest Event Ever” Had A Half-Life 1 Trillion Times Longer Than The Age Of The Universe – How Did We See It?
  • Meet The Bille, A Self-Righting Tetrahedron That Nobody Was Sure Could Exist
  • Neurogenesis Confirmed: Adult Brains Really Do Make New Hippocampal Neurons
  • RFK Jr Suggested Letting Bird Flu Run Through Farms – Experts Still Think It’s A Bad Idea
  • “For Unknown Reasons”: Mystery Of The Oldest Human Remains Ever Found In Antarctica
  • Alaska’s Wilderness At Risk As Trump Opens “Up To 82 Percent” Of National Reserve To Drilling
  • “Life-Changing” Gene Therapy Restores Hearing In Deaf Patients Within Weeks After Just One Shot
  • Man Broke Down Wall In His Basement And Discovered An Ancient Underground City That Once Housed 20,000 People
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version